Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
A growing chorus of proposals seeks to subject autonomous generative AI tools to board exams, residency programs, scope of practice determinations, and continuing medical education requirements like those of doctors as an alternative to medical device regulatory oversight.
A kidney care start-up’s scaled-down dialysis device will offer patients newfound freedom from the tribulations of end-stage renal disease.
The European Union’s AI Act retains device mandates. Excerpted from Pathways’ Picks May 13: Makary Exits FDA, EU AI Act Reforms Disappoint, UK Seeks Input, and More.